CF Acquisition Corp. V (CFV) Adds $150M to Satellogic Deal
by Marlena Haddad on 2022-01-18 at 9:24am

CF Acquisition Corp V. (NASDAQ:CFV) announced this morning that it has added $150 million to its combination with orbital imagery company Satellogic.

The new investment comes from Steven Mnuchin’s private equity firm Liberty Strategic Capital, bringing the total capital raised to more than $265 million, net of expected redemptions of CFV stock, and including a $100 million combined investment led by SoftBank and Cantor Fitzgerald, among other institutional investors.

Liberty will receive 20,000,000 ordinary shares of Satellogic at $7.50 per share, as well as 5,000,000 warrants with a strike price of $10 per share and 15,000,000 warrants with a strike price of $15 per share. The 8-K has not been filed yet, so additional details are not yet available. However, the original $100 million PIPE with Softbank and Cantor Fitzgerald was struck at $10.00 per share. It’s not clear if that will be adjusted to match the $7.50 price of the new $150 million by Liberty.

Additionally, while CFV does have a Crescent Term with a $9.20 threshold for this deal, it does not meet the criteria for an adjustment to the strike price for public warrant holders. In order to qualify for a re-strike, the aggregate gross proceeds from the PIPE must represent more than 60% of the total equity proceeds available for the funding of the combination.

The SPAC recently adjourned its shareholder meeting for the third time citing it still needed additional time to continue discussions regarding further financing for the post-combination company. The special meeting will now be held next Monday, January 24, 2022, at 11:00 a.m. EST. Upon closing, Satellogic’s ordinary shares are expected to be listed on NASDAQ under the ticker symbol “SATL”.

CF V initially announced its $850 million combination with Satellogic in July. Buenos Aires-based Satellogic provides orbital imagery and analysis services with 17 satellites in operation around the Earth.

In connection with Liberty’s investment in Satellogic, Secretary Mnuchin will join Satellogic’s Board of Directors as Non-Executive Chairman.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved